Core Insights - Evolv Technologies reported its fifth consecutive quarter of positive adjusted EBITDA, with Q4 adjusted EBITDA at $1.8 million, up from $0.4 million year-over-year, and a full-year adjusted EBITDA of $11.1 million, marking a $32 million improvement from a $21 million loss in 2024 [1][6] Financial Performance - Q4 revenue reached $38.5 million, reflecting a 32% year-over-year increase, while full-year revenue totaled $145.9 million, representing 40% growth [3][6] - Annual recurring revenue (ARR) at the end of 2025 was $120.5 million, a 21% increase year-over-year, with remaining performance obligation (RPO) at $293.4 million, up 13% year-over-year [2][6] Operational Highlights - The company deployed over 8,000 systems, screening more than 4 million people daily, and expects to exceed 10,000 units deployed by the end of 2026 [4][10] - Evolv added over 60 new customers in Q4, ending the year with more than 1,200 customers globally [10] Product and Market Developments - The eXpedite bag-screening product gained traction, with 65 customers, and 16 new customers purchasing it in Q4 [12] - Evolv raised its 2026 revenue outlook to $172 million to $178 million, with an ARR target of approximately $145 million to $150 million, indicating 20% to 25% growth [13] Margin and Cost Management - Adjusted gross margin in Q4 was 50%, down from 62% year-over-year, attributed to a shift to direct fulfillment of purchase subscription orders and a one-time accrual of approximately $1 million [5][7][8] - Management expects gross margins in 2026 to be "in line or slightly better" than 2025, despite a projected $1 million headwind from memory chip costs [9][14] Cash Flow and Financial Position - Evolv ended Q4 with $69 million in cash and cash equivalents, an increase of $12.8 million sequentially, and anticipates being cash flow positive in the second half of 2026 [17]

Financial Data and Key Metrics Changes - The company reported Q4 revenue of $38.5 million, reflecting a 32% year-over-year increase, and full-year revenue of $145.9 million, representing a 40% year-over-year growth [11][28] - Annual recurring revenue (ARR) at the end of 2025 was $120.5 million, showing a 21% year-over-year growth [11][29] - Adjusted EBITDA for 2025 was $11.1 million, compared to a loss of $21 million in 2024, marking a $32 million improvement [12][29] - Total cash equivalents and marketable securities increased by $12.8 million sequentially in Q4 to $69 million, indicating strong cash collection efforts [12][30] Business Line Data and Key Metrics Changes - The company welcomed over 60 new customers in Q4, bringing the total to over 1,200 customers globally [13] - The fourth quarter saw a 13% year-over-year increase in remaining performance obligation (RPO) to $293.4 million [13][29] - The company added 12 new school districts and 3 universities in Q4, contributing to a total of approximately 300 million students and visitors screened [15][16] Market Data and Key Metrics Changes - The company expanded its presence in the healthcare sector, screening over 1 million patients, healthcare workers, and visitors daily across medical facilities [16] - In the sports and live entertainment market, the company added 65 new customers in 2025, screening nearly 1.5 million visitors daily [18] - The workplace segment saw multiple new Fortune 500 customers, highlighting the growing demand for security solutions in high-traffic environments [20] Company Strategy and Development Direction - The company aims to build a scalable, high-growth hardware-enabled subscription business, focusing on modern technology-enabled security solutions [7][23] - The strategy includes investing in product innovation and expanding the installed base while maintaining a disciplined approach to market expansion [23][35] - The company anticipates that weapon screening will become standard infrastructure in certain buildings, similar to sprinkler systems [23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued demand for security solutions due to escalating threat levels across various public venues [7] - The company raised its 2026 revenue guidance to $172 million-$178 million, reflecting strong momentum and a healthy pipeline [22][31] - Management expects ARR growth to outpace revenue growth in 2026, with adjusted EBITDA margins expanding into the high single digits [22][35] Other Important Information - The company will host its 2026 Investor Day on June 9, 2026, to provide updates on strategy and product innovation [5][6] - The company has made significant changes to its pricing model and fulfillment strategy, which are expected to enhance long-term revenue capture [22][31] Q&A Session Summary Question: Context for raised revenue guidance and ARR growth - Management anticipates ARR to accelerate throughout the year due to changes in pricing and fulfillment strategies [40][42] Question: Overall gross margin trends - Management expects gross margins to improve in 2026 compared to 2025, driven by increased gross profit dollars from RPO [43][44] Question: Linkage between cash flow and adjusted EBITDA forecast - Management expects to be cash flow positive in the second half of 2026, with improved cash flow trajectory anticipated [49][50] Question: Mix between new and existing customers - The company reported a roughly 50/50 split between new customer acquisitions and existing customer expansions [55][67] Question: Impact of AHA certification on hospital deals - Management believes the partnership with the American Hospital Association will accelerate hospital deals, especially with regulatory changes mandating weapon screening [68]

Financial Data and Key Metrics Changes - The company reported Q4 revenue of $38.5 million, reflecting a 32% year-over-year increase, and full-year revenue of $145.9 million, representing a 40% year-over-year growth [11][25] - Annual recurring revenue (ARR) at the end of 2025 was $120.5 million, showing a 21% year-over-year growth [11][29] - Adjusted EBITDA for 2025 was $11.1 million, a significant improvement from a loss of $21 million in 2024, resulting in an adjusted EBITDA margin of 7.6% for the full year [12][29] Business Line Data and Key Metrics Changes - The company welcomed over 60 new customers in Q4, bringing the total to over 1,200 customers globally, with a strong trend of existing customers upgrading to the Gen2 Express platform [13][57] - The fourth quarter saw a 13% year-over-year increase in remaining performance obligation (RPO), reaching $293.4 million [13][30] Market Data and Key Metrics Changes - The company added 12 new school districts and three universities in Q4, screening approximately 300 million students and visitors throughout the year [15][16] - In the healthcare sector, the company is now screening over 1 million patients, healthcare workers, and visitors daily across medical facilities [16][21] Company Strategy and Development Direction - The company aims to build a scalable, high-growth hardware-enabled subscription business, emphasizing the importance of security solutions in a complex global environment [7][24] - The company is focused on expanding its product portfolio, particularly with the early success of its eXpedite autonomous AI-based bag screening solution [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued demand for modern technology-enabled security solutions, anticipating that weapon screening could become standard infrastructure in various buildings [24][23] - The company raised its revenue guidance for 2026 to a range of $172 million to $178 million, expecting ARR growth of 20% to 25% [23][33] Other Important Information - The company reported a cash increase of $12.8 million sequentially in Q4, totaling $69 million, highlighting strong cash collection efforts [12][31] - The company plans to host its 2026 Investor Day on June 9, 2026, to provide further updates on strategy and financial outlook [5][6] Q&A Session Summary Question: Context for raised revenue guidance and ARR growth - Management anticipates ARR to accelerate throughout the year due to changes in pricing and fulfillment models, which will take time to reflect in ARR per unit [42][44] Question: Overall adjusted gross margins trend - Management expects gross margins to be in line or slightly better in 2026 compared to 2025, with more gross profit dollars being pushed into RPO [45][46] Question: Linkage between cash flow and adjusted EBITDA forecast for 2026 - Management expects to be cash flow positive in the second half of 2026, with improved cash flow trajectory anticipated [51][52] Question: Mix between new logos and existing customers - The company reported a 50/50 split between new customer acquisitions and existing customer expansions, which is expected to continue [72][72] Question: Impact of AHA certification on hospital deals - Management is optimistic that the AHA partnership will accelerate hospital deals, especially with regulatory changes mandating weapon screening [74][74]

Financial Data and Key Metrics Changes - The company reported Q4 revenue of $38.5 million, reflecting a 32% year-over-year increase, and full-year revenue of $145.9 million, representing a 40% year-over-year growth [11][26] - Annual recurring revenue (ARR) at the end of 2025 was $120.5 million, showing a 21% year-over-year growth [11][30] - Adjusted EBITDA for 2025 was $11.1 million, compared to a loss of $21 million in 2024, marking a $32 million improvement [12][30] - Total cash equivalents and marketable securities increased by $12.8 million sequentially in Q4 to $69 million, indicating strong cash collection efforts [12][31] Business Line Data and Key Metrics Changes - The company added over 60 new customers in Q4, bringing the total to over 1,200 customers globally [13][56] - The fourth quarter saw a 13% year-over-year increase in remaining performance obligation (RPO), reaching $293.4 million [13][30] - The company reported strong demand for its Gen Two Express platform, with existing customers upgrading [13][30] Market Data and Key Metrics Changes - The company continues to expand in the education sector, adding 12 new school districts and 3 universities in Q4, screening approximately 300 million students and visitors throughout the year [16][17] - In healthcare, the company is now screening over 1 million patients, healthcare workers, and visitors daily across medical facilities [17] - The sports and live entertainment market saw the addition of 65 new customers in 2025, with nearly 1.5 million visitors screened daily [19][20] Company Strategy and Development Direction - The company aims to build a scalable, high-growth hardware-enabled subscription business, focusing on modern technology-enabled security solutions [6][7] - The strategy includes investing in product innovation and expanding the customer base while maintaining a disciplined approach to working capital management [24][25] - The company anticipates that weapon screening will become standard infrastructure in certain buildings, similar to sprinkler systems [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued demand for security solutions due to escalating threat levels in public venues and workplaces [6][7] - The company raised its revenue guidance for 2026 to a range of $172 million to $178 million, expecting ARR growth of 20% to 25% [24][32] - Management highlighted the importance of innovation in weapon detection accuracy and cost as key to maintaining a competitive edge [25] Other Important Information - The company will host its 2026 Investor Day on June 9, 2026, to provide updates on strategy and product innovation [5] - The company is transitioning to a direct fulfillment model for purchase subscriptions, which is expected to enhance revenue and gross profit over time [26][30] Q&A Session Summary Question: Context for raised revenue guidance despite modest sequential ARR growth - Management anticipates ARR to accelerate throughout the year due to changes in pricing and fulfillment models [41][43] Question: Overall adjusted gross margins trend for 2026 - Management expects gross margins to be in line or slightly better in 2026 compared to 2025, with more gross profit dollars being pushed into RPO [44][45] Question: Timing for production from Plexus relationship - Management confirmed that full ramp with Plexus is expected in the second half of 2026, which will provide a tailwind to gross margins [46][47] Question: Mix between new logos and existing customers - Management indicated a consistent 50/50 split between new customer acquisitions and existing customer expansions [55][69] Question: Impact of AHA certification on hospital deals - Management expressed optimism that the AHA partnership will accelerate hospital deals, especially with regulatory changes mandating weapon screening [70]

Evolv Technologies Conference Call Summary Company Overview - **Company**: Evolv Technologies - **Industry**: AI-enabled touchless security screening - **Founded**: 2013 - **Key Products**: Evolv Express (for people screening) and Evolv eXpedite (for bag screening) [1][10] Core Insights and Arguments - **Mission**: To make the world a safer and more enjoyable place through innovative security solutions [4] - **Market Need**: The company was inspired by tragic events, including the Boston Marathon bombing and numerous mass shootings, highlighting the urgent need for improved security measures [2][3][4] - **Technology Innovation**: Evolv Technologies focuses on using advanced technology, sensors, and AI to differentiate between weapons and personal items, allowing for quick and efficient screening [7][8][17] - **Operational Efficiency**: The technology aims to reduce wait times and improve the experience for users while maintaining high security standards [10][33] Market Opportunity - **Total Addressable Market (TAM)**: Estimated at $20 billion, targeting sectors such as education, healthcare, sports, entertainment, and industrial workplaces [17] - **Customer Base**: Approximately 1,000 customers, primarily in the U.S., including sports venues, schools, hospitals, and casinos [18][19] - **Growth Potential**: The company sees significant growth opportunities, especially in light of increasing violence and the need for effective security solutions [57][67] Product Features and Performance - **Evolv Express**: Allows individuals to walk through without stopping, identifying concealed threats quickly [10] - **Evolv eXpedite**: Automates bag screening, significantly faster than traditional X-ray systems [13] - **Data Utilization**: The system collects data on screening events, helping customers optimize staffing and security operations [42][44] Challenges and Considerations - **False Positives**: The system experiences nuisance alarms, with rates varying based on settings and environments, but aims to minimize disruption [26][28] - **Market Awareness**: The primary challenge is increasing awareness of the technology and its benefits compared to traditional methods [50][52] - **International Expansion**: Currently, less than 10% of business is international, but there are plans for growth in global markets [66][67] Future Outlook - **Technological Adaptability**: The company is committed to continuously updating its algorithms and technology to address evolving threats [20] - **Long-term Contracts**: Evolv engages customers with four-year non-cancelable contracts, fostering strong relationships and ongoing collaboration [45] - **Network Effect**: The large customer base enhances the effectiveness of the technology through shared learnings and data [46] Additional Insights - **Security Trends**: The company notes a shift in security approaches, with more organizations seeking advanced screening technologies due to recent violent events [29][30] - **Event Security**: Major events like the World Cup and Olympics are driving interest in efficient and effective security solutions [31][33] - **Manufacturing Partnerships**: Evolv has partnered with Plexus for manufacturing, enhancing scalability and operational capacity [37][38] This summary encapsulates the key points discussed during the Evolv Technologies conference call, highlighting the company's mission, market opportunities, product innovations, and future growth strategies.

Company Overview - Evolv Technologies Holdings operates at the intersection of security and artificial intelligence, providing scalable, touchless screening solutions for public venues, addressing the demand for efficient security in high-traffic environments [1] - The company generates revenue through hardware sales, software subscriptions, and analytics platforms that offer security insights and operational data to clients [2] Recent Financial Performance - In the third quarter, revenue increased by 57% year over year to $42.9 million, while annual recurring revenue rose by 25% to $117.2 million [8] - Adjusted EBITDA turned positive at $5.1 million, and management raised full-year 2025 revenue guidance to between $142 million and $145 million, indicating potential growth of up to 40% [8] Insider Transactions - John Kedzierski, the president and CEO, sold 74,322 shares at $7.03 per share, totaling approximately $522,483.66, following the exercise of 207,000 options [4][5] - The sale reduced Kedzierski's direct ownership by 34.57%, from 215,000 to 140,678 shares, with no indirect holdings reported post-transaction [3][5] - The transaction was executed to cover withholding taxes from the vesting of restricted stock units, rather than indicating a reduction in conviction [7][9]

Group 1 - Evolv Technologies Holdings Inc. (NASDAQ:EVLV) is recognized as a promising small-cap industrial stock priced under $50, with a bullish outlook from analysts [1] - Northland Securities analyst Michael Latimore has reaffirmed a Buy rating for Evolv Technologies, setting a price target of $9.5, indicating a potential upside of nearly 38% for investors [1] - The consensus among analysts is positive, with all four covering Evolv Technologies assigning Buy ratings, leading to an estimated 1-year average price target of $9.83, which suggests a 39.4% upside from the current stock level [2] Group 2 - On December 16, Evolv Technologies announced the deployment of its Evolv Express product at Pechanga Arena, a 14,000-seater venue in San Diego, marking an expansion of its presence in key locations [3] - Evolv Technologies specializes in AI-enabled security solutions, providing end-to-end security screening and analytics for public venues, hospitals, and schools [4]

Company Overview - Evolv Technologies provides AI-based touchless security screening systems designed to detect firearms, improvised explosive devices, and tactical knives as visitors walk through at a normal pace [5][8] - The company generates revenue through the sale and subscription of hardware and software solutions for security screening, analytics, and visitor management, serving sectors such as entertainment, education, healthcare, and other public spaces [8] Financial Performance - As of November 20, 2025, Evolv Technologies had a market capitalization of $987.46 million, with a revenue of $136.50 million and a net income of -$59.74 million for the trailing twelve months (TTM) [4] - In the most recent quarter, sales grew by 57%, and annual recurring revenue increased by 25%, with management expecting to generate positive operating cash flows in the upcoming quarter [11] Investment Position - Mittelman Wealth Management initiated a new position in Evolv Technologies, acquiring 1,511,866 shares valued at $11.41 million, representing a 7.47% allocation of the fund's $152.74 million in reportable U.S. equity assets [2][3] - Evolv Technologies has become the sixth-largest position for Mittelman Wealth Management, indicating strong institutional interest in the stock [9] Market Performance - As of November 20, 2025, Evolv's shares were priced at $5.66, reflecting a 107.0% increase over the past year, significantly outperforming the S&P 500 by 97 percentage points [3] - The stock is trading at 7 times sales, which is comparatively lower than a peer like Axon Enterprise, which trades at 16 times sales, suggesting a potentially attractive investment opportunity [11]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $42.9 million, representing a 57% year-over-year increase, driven by strong new customer acquisition and expanded deployments [7][21] - Annual recurring revenue (ARR) reached $117.2 million, reflecting a 25% year-over-year growth [11][25] - Adjusted EBITDA was positive at $5.1 million, compared to a loss of $3 million in the same quarter last year, resulting in an adjusted EBITDA margin of 12% [28][29] - Adjusted gross margin was 51% in Q3, down from 64% in the same period last year [27][29] Business Line Data and Key Metrics Changes - The company welcomed over 60 new customers in Q3, raising the year-end estimate for active subscriptions to between 8,000 and 8,100 [12][21] - The deployment of the new autonomous AI-powered bag screening solution, Expedite, gained traction with 12 new customers added in Q3, primarily in schools [13][19] - The company reported a sequential 8% increase in remaining performance obligation (RPO), which stood just shy of $300 million at the end of Q3 [12][25] Market Data and Key Metrics Changes - The company noted strong demand across various sectors, including education, healthcare, and sports, with significant contracts signed in these markets [16][17] - The largest customer contract in the company's history, involving more than 250 units, contributed approximately $3 million in revenue in Q3 [25][30] Company Strategy and Development Direction - The company is transitioning to a direct distribution model, which is expected to enhance recurring revenue and cash flow over time [10][23] - The management emphasized the importance of ARR growth and plans to add more units in 2026 than in 2025, with expectations for ARR growth to outpace total revenue growth [22][35] - A new strategic partnership with Plexus aims to expand production capacity and operational resiliency [18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's market position and the ongoing transition to a direct fulfillment model, which simplifies the buying process for channel partners [45][46] - The company raised its 2025 revenue growth outlook to 37%-40%, up from previous guidance of 27%-30% [21][29] - For 2026, the company anticipates revenue of $160 million to $165 million, with ARR expected to grow by at least 20% year-over-year [34][35] Other Important Information - The company has made significant product updates, including new software versions aimed at improving performance and user experience [19][20] - The company screened over 3 billion visitors since the launch of Evolv Express, demonstrating the impact of its technology on community safety [13][14] Q&A Session Summary Question: Can you help me understand the revenue recognition for the large contract? - Management explained that the legacy distribution model results in more upfront revenue, but they expect normalization in revenue recognition as they transition to direct fulfillment [40][41] Question: What impact do you expect from the new strategic contract manufacturer agreement? - Management anticipates cost synergies and larger scale manufacturing capabilities from the partnership with Plexus, which will eventually include all product lines [42] Question: What is the attachment rate for Expedite with Express machines? - Management reported that 11 out of 12 new Expedite customers also acquired Express, indicating strong cross-selling success [43] Question: What percentage of bookings came from existing customers? - Over 50% of bookings came from existing customers, with significant expansions noted [47] Question: Are there promising new verticals for growth? - The company sees opportunities in various sectors, including sports, entertainment, education, and healthcare, while maintaining a consistent vertical mix [48]

Group 1 - Evolv Technologies Holdings Inc. is recognized as a promising small-cap AI stock by hedge funds [1] - The company has renewed and expanded its partnership with Gillette Stadium, which includes an increase in the number of entry points utilizing its AI-based Evolv Express security screening systems [1][2] - The Evolv Express system is designed to detect concealed weapons while allowing visitors to pass through checkpoints at their natural walking pace, thereby minimizing congestion [3] Group 2 - Evolv Technologies provides AI-based weapons detection for security screening both in the US and internationally, with its flagship product being the Evolv Express [4]